LUCID DIAGNOSTICS INC's ticker is and the CUSIP is 54948X109. A total of 31 filers reported holding LUCID DIAGNOSTICS INC in Q1 2024. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $595,177 | +2.4% | 725,825 | +1.1% | 0.34% | +29.9% |
| Q1 2024 | $581,230 | -46.7% | 717,657 | -7.2% | 0.26% | -12.3% |
| Q4 2023 | $1,090,277 | +6.5% | 773,246 | -11.6% | 0.30% | -4.7% |
| Q3 2023 | $1,023,867 | -16.1% | 875,100 | -0.4% | 0.32% | -13.9% |
| Q2 2023 | $1,220,945 | +2.0% | 878,378 | +2.7% | 0.37% | +24.4% |
| Q1 2023 | $1,197,420 | +6.7% | 855,300 | +3.7% | 0.30% | +5.4% |
| Q4 2022 | $1,122,000 | -13.4% | 825,000 | -2.6% | 0.28% | -38.1% |
| Q3 2022 | $1,295,000 | -34.4% | 846,662 | -3.1% | 0.45% | -25.7% |
| Q2 2022 | $1,975,000 | -22.2% | 873,804 | +15.7% | 0.61% | +7.0% |
| Q1 2022 | $2,538,000 | -62.4% | 755,482 | -39.9% | 0.57% | -64.2% |
| Q4 2021 | $6,756,000 | – | 1,258,064 | – | 1.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayrton Capital LLC | 73,907 | $86,471 | 0.59% |
| LUMINUS MANAGEMENT LLC | 875,100 | $1,023,867 | 0.32% |
| Nantahala Capital Management | 158,135 | $185,018 | 0.02% |
| Byrne Asset Management LLC | 7,210 | $8,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 135,000 | $157,950 | 0.00% |
| Geneos Wealth Management Inc. | 33,850 | $39,605 | 0.00% |
| WELLS FARGO & COMPANY/MN | 9,077 | $10,620 | 0.00% |
| JANE STREET GROUP, LLC | 17,322 | $20,267 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 5,516 | $6,454 | 0.00% |